EUVIMEDEUVIMED entdecken
Open Access

Epidemiology of early vs late recurrence among women with early stage estrogen receptor–positive breast cancer in the Pathways Study

Alfredo V Chua iD, Haiyang Sheng, Emily Liang, Shipra Gandhi, Marilyn L Kwan, Isaac J Ergas iD, Janise M Roh iD, Cecile A Laurent, Li Yan, Thaer Khoury, Christine B Ambrosone iD, Lawrence H Kushi und 1 weitere

JNCI: Journal of the National Cancer Institute · 2024

DOI: 10.1093/jnci/djae128 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JNCI: Journal of the National Cancer Institute, 2024. Verfasst von Alfredo V Chua und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA. Hauptthemen laut MEDLINE: Breast Neoplasms, Neoplasm Recurrence, Local, Receptors, Estrogen, Neoplasm Staging. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, Breast Cancer Research Foundation, The Roswell Park Data Bank and BioRepository.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Relatively little is known about the differences in prognostic factors for early vs late recurrence among women with early stage estrogen receptor–positive breast cancer.

Methods

We analyzed factors related to early (<5 years) vs late (≥5 years) recurrence in 2992 women with stage I-IIB estrogen receptor–positive breast cancer in the Pathways Study, a prospective cohort of women with breast cancer enrolled between 2006 and 2013, with ascertainment of recurrence and death through December 2021.

Results

After a median follow-up of 13.3 years, 341 (13.8%) women had recurrences, including 181 (53.7%) with late recurrence. Higher stage and grade were associated with recurrence regardless of timing, whereas progesterone receptor negativity was associated with early but not late recurrence. Receipt of endocrine therapy was associated with reduced risk of overall recurrence, but the length of endocrine therapy was not statistically significant in multivariable models. Minoritized racial and ethnic groups, including Asian, Black, and Hispanic women, had higher risk of early but not late recurrence compared to non-Hispanic White women. The trend of higher risk of early recurrence among these groups remained after adjustment for clinical, demographic, and socioeconomic factors but was statistically significant only in Asian women.

Conclusions

Our study revealed potentially important distinctions for early vs late recurrence, including the associations with progesterone receptor negativity and self-identified race and ethnicity. Possible higher risk of early recurrence among Asian, Black, and Hispanic women provides novel evidence for the existence of disparities in cancer outcomes, even within the breast cancer subtype indicative of generally good prognosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsNeoplasm Recurrence, LocalReceptors, EstrogenNeoplasm StagingHumansFemaleMiddle AgedAgedProspective StudiesPrognosisAdultReceptors, ProgesteroneFollow-Up StudiesRisk FactorsUnited StatesTime Factors

Substanzen

Receptors, EstrogenReceptors, Progesterone

Autor:innen und Institutionen

  • Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
  • Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, NY, USA.
  • Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
  • Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA.
  • Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
  • Department of Pathology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.

ORCID-Profile: Alfredo V Chua, Isaac J Ergas, Janise M Roh, Christine B Ambrosone, Song Yao

Förderung

  • NCI NIH HHS
  • Breast Cancer Research Foundation
  • The Roswell Park Data Bank and BioRepository
  • NIH HHS
  • National Cancer Institute
  • National Institutes of Health
  • Cancer Center Support Grant Shared Resource

Zitieren

APA

Chua, A. V., Sheng, H., Liang, E., Gandhi, S., Kwan, M. L., Ergas, I. J., Roh, J. M., Laurent, C. A., Yan, L., Khoury, T., Ambrosone, C. B., Kushi, L. H., & Yao, S. (2024). Epidemiology of early vs late recurrence among women with early stage estrogen receptor–positive breast cancer in the Pathways Study. JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djae128

Vancouver

Chua AV, Sheng H, Liang E, Gandhi S, Kwan ML, Ergas IJ, et al. Epidemiology of early vs late recurrence among women with early stage estrogen receptor–positive breast cancer in the Pathways Study. JNCI: Journal of the National Cancer Institute. 2024. doi:10.1093/jnci/djae128

BibTeX
@article{Chua2024,
  author = {Chua, Alfredo V and Sheng, Haiyang and Liang, Emily and Gandhi, Shipra and Kwan, Marilyn L and Ergas, Isaac J and Roh, Janise M and Laurent, Cecile A and Yan, Li and Khoury, Thaer and Ambrosone, Christine B and Kushi, Lawrence H and Yao, Song},
  title = {Epidemiology of early vs late recurrence among women with early stage estrogen receptor–positive breast cancer in the Pathways Study},
  journal = {JNCI: Journal of the National Cancer Institute},
  year = {2024},
  doi = {10.1093/jnci/djae128}
}
Kostenlos starten →